AB22002 - A dose-ranging study to investigate efficacy and safety of buntanetap in participants with early AD

Clinical Trial Grant

Duke Scholars

Principal Investigator Laurie H Sanders Neurology, Movement Disorders

Administered By

Duke Clinical Research Institute

Awarded By

Annovis Bio, Inc.

Start Date

December 7, 2022

End Date

August 8, 2024

Administered By

Duke Clinical Research Institute

Awarded By

Annovis Bio, Inc.

Start Date

December 7, 2022

End Date

August 8, 2024